CD36 and myocardial infarction: The clinical relevance of the CD36 signaling pathway in thrombotic vascular disease is evidenced by human genetic studies identifying polymorphisms in the CD36 gene that are strongly associated with platelet surface CD36 expression and risk of acute myocardial infarction [119,120].